+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the Infectious Disease Consultant in Management of Patients With Tuberculosis-Associated Ocular Inflammation



Role of the Infectious Disease Consultant in Management of Patients With Tuberculosis-Associated Ocular Inflammation



Open Forum Infectious Diseases 3(1): Ofv195



Background.  Tuberculosis is a disease with continued worldwide prevalence, morbidity, and mortality. Tuberculosis-associated ocular inflammation (TB-AOI) is a manifestation that can occur with pulmonary or extrapulmonary TB. Evaluation of these ocular presentations and treatment in the United States are limited. Our objective was to describe cases in an urban area and assess the role of the infectious diseases specialist in managing these complex patients. Methods.  We performed a retrospective case series of all patients referred to our infectious disease clinic for presumed TB-AOI from 2005 through 2013. Patients with ocular inflammation were determined to have presumed TB-AOI based on clinical presentation with correlative positive tuberculin skin test and/or QuantiFERON-TB Gold. Attempts were made to exclude other diagnoses. Data were collected and analyzed with respect to demographics, ocular manifestations, and treatment. Results.  Sixty eyes of 42 patients were included in the study; anterior uveitis was the most common site of involvement. The median age was 46 years, and 33 patients (79%) were foreign born. Forty patients (95%) received a course of antituberculous therapy with 38% experiencing treatment-related side effects. A 6-month duration was recommended in 78% cases. There was improvement or stability of the vision in 42 eyes (74%) of those treated. Conclusions.  Ocular involvement is an uncommon but important manifestation of TB. Our data further characterize TB-AOI cases in the United States. Treatment provides significant benefit to properly selected patients. A multidisciplinary approach, with care provided by ophthalmology and infectious disease providers, should be used to allow for the most efficacious treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791086

Download citation: RISBibTeXText

PMID: 26811844

DOI: 10.1093/ofid/ofv195


Related references

A role for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis. Parasitology 115 Suppl: S113-S125, 1997

Can rituximab induce long-term disease remission in patients with intra-ocular non-infectious inflammation?. Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 230(3): 109-115, 2014

Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study. Bmc Infectious Diseases 13: 225, 2014

QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. American Journal of Ophthalmology 152(3): 433-440.E1, 2011

Ocular inflammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular inflammation. European Journal of Ophthalmology 18(4): 563-566, 2008

Patterns of ocular inflammation in patients with miliary tuberculosis. F1000research 6: 412, 2017

Update on Immunological Test (Quantiferon-TB Gold) Contribution in the Management of Tuberculosis-Related Ocular Inflammation. Ocular Immunology and Inflammation 26(8): 1192-1199, 2017

Management of mycobacteriosis in general hospital without isolation ward for tuberculosis patients. 4. Actual status of the management of tuberculosis patients in a university hospital without isolation wards for infectious diseases. Kekkaku 74(2): 145-150, 1999

Integrating iquix, vigamox, and zymar in the management of ocular infectious disease. International Ophthalmology Clinics 46(4): 41-45, 2006

Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Advances in Experimental Medicine and Biology 506(Pt B): 729-738, 2003

A role for granulomatous inflammation in the transmission of infectious disease Schistosomiasis and TB too?. Immunology 92(SUPPL 1): 4, 1997

Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease. Veterinary Pathology 36(5): 357-367, 1999

Introduction: The role of inflammation, autoimmune disease and infectious agents in development of leukaemia and lymphoma. Journal of Internal Medicine 264(6): 512-513, 2008

What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Diagnostic role of adenosine deaminase activity measurement in tuberculosis. Revue des Maladies Respiratoires 21(3 Pt 2): S44-S50, 2004

The infectious disease consultant and the telephone consultation. Pediatric Infectious Disease 5(1): 51-53, 1986